Cargando…

Subacute Massive Pulmonary Embolism Treated With Streptokinase

Subacute massive pulmonary embolism occurs insidiously over weeks, has a high mortality rate, and may be less amenable to systemic thrombolysis. It is associated with a high likelihood of the development of pulmonary hypertension. The subacute presentation makes it difficult to diagnose leading to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Solanki, Naisargee N, Tanwar, Narendra, Solanki, Nilesh D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686918/
https://www.ncbi.nlm.nih.gov/pubmed/33251065
http://dx.doi.org/10.7759/cureus.11157
_version_ 1783613423679963136
author Solanki, Naisargee N
Tanwar, Narendra
Solanki, Nilesh D
author_facet Solanki, Naisargee N
Tanwar, Narendra
Solanki, Nilesh D
author_sort Solanki, Naisargee N
collection PubMed
description Subacute massive pulmonary embolism occurs insidiously over weeks, has a high mortality rate, and may be less amenable to systemic thrombolysis. It is associated with a high likelihood of the development of pulmonary hypertension. The subacute presentation makes it difficult to diagnose leading to treatment delays and poor clinical outcomes. We present a case of a 40-year-old man with unprovoked pulmonary embolism and no evidence of deep vein thrombosis. The patient underwent systemic thrombolysis with streptokinase and was given long-term oral anticoagulants. A dramatic clinical recovery was seen along with significant clearance of the thrombus.
format Online
Article
Text
id pubmed-7686918
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-76869182020-11-27 Subacute Massive Pulmonary Embolism Treated With Streptokinase Solanki, Naisargee N Tanwar, Narendra Solanki, Nilesh D Cureus Cardiology Subacute massive pulmonary embolism occurs insidiously over weeks, has a high mortality rate, and may be less amenable to systemic thrombolysis. It is associated with a high likelihood of the development of pulmonary hypertension. The subacute presentation makes it difficult to diagnose leading to treatment delays and poor clinical outcomes. We present a case of a 40-year-old man with unprovoked pulmonary embolism and no evidence of deep vein thrombosis. The patient underwent systemic thrombolysis with streptokinase and was given long-term oral anticoagulants. A dramatic clinical recovery was seen along with significant clearance of the thrombus. Cureus 2020-10-25 /pmc/articles/PMC7686918/ /pubmed/33251065 http://dx.doi.org/10.7759/cureus.11157 Text en Copyright © 2020, Solanki et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Solanki, Naisargee N
Tanwar, Narendra
Solanki, Nilesh D
Subacute Massive Pulmonary Embolism Treated With Streptokinase
title Subacute Massive Pulmonary Embolism Treated With Streptokinase
title_full Subacute Massive Pulmonary Embolism Treated With Streptokinase
title_fullStr Subacute Massive Pulmonary Embolism Treated With Streptokinase
title_full_unstemmed Subacute Massive Pulmonary Embolism Treated With Streptokinase
title_short Subacute Massive Pulmonary Embolism Treated With Streptokinase
title_sort subacute massive pulmonary embolism treated with streptokinase
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686918/
https://www.ncbi.nlm.nih.gov/pubmed/33251065
http://dx.doi.org/10.7759/cureus.11157
work_keys_str_mv AT solankinaisargeen subacutemassivepulmonaryembolismtreatedwithstreptokinase
AT tanwarnarendra subacutemassivepulmonaryembolismtreatedwithstreptokinase
AT solankinileshd subacutemassivepulmonaryembolismtreatedwithstreptokinase